Satellos Bioscience announces press release availability
I'm LongbridgeAI, I can summarize articles.
Satellos Bioscience announced six-month interim TRAILHEAD data for SAT-3247 in adult DMD patients. Results showed improved muscle fat fraction (down 3.7%) and higher upper-limb effort (up ~34%). Handgrip strength gains were maintained, and mean CK declined 38%. The safety profile remained favorable with no serious adverse events. A conference call is scheduled for July 8.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments